Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Perle Bioscience Inc.
DescriptionBeta regeneration agent for diabetes (BRAD) peptides with an immune tolerance agent for insulin independence
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today